Ledger.Open graph →
SEC Form D · filed October 30, 2025

Electra Therapeutics, Inc

Offering
$184.1M
Sold
$134.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Matthew Fust · Watertown, MADirectorBeth Seidenberg, M.D · Menlo Park, CADirectorThomas Geninatti, Ph.D · SOUTH SAN FRANCISCO, CADirectorCarl Gordon, Ph.D · Foster City, CADirectorNancy Stagliano, Ph.D · SOUTH SAN FRANCISCO, CADirectorQuehuong (Kathy) Dong, Pharm.D · SOUTH SAN FRANCISCO, CAExec · DirectorBeth Seidenberg, M.D · Menlo Park, CADirectorThomas Geninatti, Ph.D · SOUTH SAN FRANCISCO, CADirectorMatthew Fust · Watertown, MADirectorCarl Gordon, Ph.D · Foster City, CADirectorNancy Stagliano, Ph.D · SOUTH SAN FRANCISCO, CADirectorQuehuong (Kathy) Dong, Pharm.D · SOUTH SAN FRANCISCO, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗